Go to the list of all blogs
Harry Richardson's Avatar
published in Blogs
Nov 18, 2026
TickeronGET DAILY SIGNALS
F.N.B. Corporation (FNB): Weighing the Path to a $20 Target and +13% Upside

F.N.B. Corporation (FNB): Weighing the Path to a $20 Target and +13% Upside

Key Takeaways

  • The central $20 target is the arithmetic mean of eight current analyst price targets reviewed, rounded from roughly $20.2; it implies about 13% upside from the latest price near $17.64.
  • The verified analyst price target range is approximately $19 to $22, with KBW and Piper Sandler at the high end and BofA, UBS, and Truist clustered near the low end.
  • Supporting factors include a roughly 2.9% dividend yield, a price-to-book ratio near 0.94, steady EPS growth expectations, and a Buy-leaning analyst consensus.
  • Key risks include a Q3 revenue miss versus consensus, several recent downward target revisions, a Bank of America downgrade to Neutral, and the stock's break below its 200-day moving average.
  • For additional context, readers can explore Major News, Today's Price Move, Forecast, and Earnings pages for this ticker.
  • Investors seeking AI-driven market insights can explore Trending AI Robots.

Analyst Price Targets and Consensus View

The $20 central target reflects the average of eight current, attributable analyst price targets, not a single firm's view. The most recent targets span a range of $19 to $22. At the top, KBW reiterated a $22 target (October 21, 2026) and Piper Sandler maintained $22 (October 20, 2026). Wells Fargo holds an Overweight rating with a $21 target after trimming from $22 in late September. Raymond James lowered its target to $20 from $21 (October 21), while UBS ($19, Hold), Truist Securities ($19, Buy), and Bank of America Securities ($19, Hold) sit near the lower end. Investec carries a $19.50 Hold target from April.

Recent revisions tilt cautious: BofA downgraded FNB to Neutral from Buy, and Truist and Wells Fargo each trimmed targets in September and October, reflecting softer revenue momentum. Even so, the consensus remains "Moderate Buy," with most firms rating the shares Buy or Overweight. The dispersion is narrow — the spread between the $19 low and $22 high is only about $3 — signaling that analysts generally agree on the bank's core earnings power while differing modestly on valuation and near-term net interest income trends. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Current Market Position and Path Toward the Target

With shares near $17.64, reaching $20 requires a modest advance of roughly 13%. That is a realistic but not automatic climb for a regional bank trading at about 10 times trailing earnings and below book value. FNB reported third-quarter EPS of $0.43, matching consensus, but revenue of $469 million came in below the roughly $476 million Street estimate — a reminder that loan growth and net interest income remain the key swing factors. Analysts project full-year EPS of about $1.69 on revenue near $1.87 billion, implying low-single-digit earnings growth.

The path toward $20 would likely depend on stabilizing net interest margin, continued expense discipline, and renewed investor confidence that credit quality stays benign. FNB also recently announced a dividend increase and a $250 million share buyback, supportive signals for total shareholder returns. From what I see, these capital return moves add a layer of support worth watching.

What Could Support a Move Toward the Target

  • Attractive valuation: a price-to-book ratio near 0.94 and a P/E around 10 leave room for re-rating if earnings hold up.
  • Income appeal: a dividend yield near 2.9%, backed by a recent increase and buyback authorization.
  • Steady earnings growth: consensus points to EPS rising from about $1.59 to $1.69 this year and toward $1.89 next year.
  • Constructive analyst posture: a Buy-leaning consensus, with KBW and Piper Sandler maintaining $22 targets, reflects confidence in execution and diversification across banking, wealth, and insurance.

What Could Prevent the Target From Being Reached

  • Revenue softness: the Q3 top-line miss highlights pressure on net interest income if loan growth slows or funding costs stay elevated.
  • Downward revisions: BofA's downgrade to Neutral and the recent target cuts from Truist and Wells Fargo suggest analysts see limited near-term catalysts.
  • Macro and rate sensitivity: as a regional lender, FNB is exposed to interest-rate policy, deposit competition, and any deterioration in commercial credit quality.
  • Technical pressure: shares recently slipped below the 200-day moving average near $17.93, which can act as overhead resistance until reclaimed.

Technical Levels and Market Structure

The 52-week range spans roughly $15.21 to $19.59. The 50-day moving average sits near $17.78 and the 200-day near $17.93; with the stock trading just below both, a sustained move back above $18 would be an early sign of stabilization. The $19.50–$19.60 area, near the prior high, marks the first major resistance level, with $20 as the next psychological round-number milestone before the $21–$22 zone where the highest analyst targets sit. I’m watching this closely for any break that could confirm momentum.

Time Horizon and What Investors Should Monitor

Analyst price targets typically reflect a roughly 12-month forward view, though individual firms rarely state an identical horizon. Investors should watch the next quarterly earnings release, management's guidance on net interest income and loan growth, any further analyst rating or target changes, and Federal Reserve interest-rate decisions, which directly affect regional-bank profitability. Credit quality metrics and buyback execution are additional items worth monitoring.

Using AI Daily Buy/Sell Signals in Practice

In my own research process, Tickeron’s AI Daily Buy/Sell Signals have proven useful for spotting shifts in stocks like FNB without having to manually scan charts every day. The tool applies AI to track thousands of names and flag Buy, Sell, or Hold ideas based on technicals and market conditions, which helps me cross-check fundamental views with real-time signals. It serves as a practical complement when evaluating whether a name is approaching a key level or showing signs of stabilization.

Final Assessment

The question of whether F.N.B. Corporation can reach $20 is best understood as a valuation-and-execution question rather than a directional bet. The $20 central target, an average of eight analyst targets spanning $19 to $22, sits about 13% above the current price. Support comes from an inexpensive valuation, a healthy dividend, steady projected EPS growth, and a Buy-leaning consensus. The principal obstacles are soft revenue momentum, a cluster of recent downward revisions, and technical resistance near prior highs. Whether shares bridge that gap will hinge on net interest income trends, credit quality, and the broader rate environment — factors investors should continue to monitor closely.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: FNB

Contributor

Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.


Momentum Indicator for FNB turns negative, indicating new downward trend

FNB saw its Momentum Indicator move below the 0 level on November 16, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 85 similar instances where the indicator turned negative. In 56 of the 85 cases, the stock moved further down in the following days. The odds of a decline are at 66%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for FNB turned negative on November 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 24 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 57%.

FNB moved below its 50-day moving average on November 17, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FNB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The 10-day moving average for FNB crossed bullishly above the 50-day moving average on October 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 44%.

Following a +1.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where FNB advanced for three days, in 165 of 296 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.

FNB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 117 of 269 cases where FNB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 43%.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 11 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 30 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. FNB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 52 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.932) is normal, around the industry mean (1.262). P/E Ratio (10.592) is within average values for comparable stocks, (13.479). Projected Growth (PEG Ratio) (1.530) is also within normal values, averaging (1.190). Dividend Yield (0.029) settles around the average of (0.036) among similar stocks. P/S Ratio (3.524) is also within normal values, averaging (3.738).

Notable companies

The most notable companies in this group are US Bancorp (NYSE:USB), PNC Financial Services Group (NYSE:PNC), Itau Unibanco Banco Holding SA (NYSE:ITUB), Deutsche Bank Aktiengesellschaft (NYSE:DB), Huntington Bancshares (NASDAQ:HBAN), Banco Bradesco SA (NYSE:BBD), Regions Financial Corp (NYSE:RF), KeyCorp (NYSE:KEY).

Industry description

Regional banks have a smaller reach than major banks, and cater mostly to one region of a country, such as a state or within a group of states. They offer services often similar – albeit with some limitations/smaller scale – compared to major banks. Taking deposits, making loans, mortgages, leases, credit cards , fund management, insurance and investment banking. SunTrust Banks, State Street Corp., M&T Bank Corp. are some examples of U.S. regional banks.

Market Cap

The average market capitalization across the Regional Banks Industry is 6.03B. The market cap for tickers in the group ranges from 147.87 to 173.74B. DBSDF holds the highest valuation in this group at 173.74B. The lowest valued company is VLYPP at 147.87.

High and low price notable news

The average weekly price growth across all stocks in the Regional Banks Industry was -2%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was 6%. AGBK experienced the highest price growth at 20%, while AVAL experienced the biggest fall at -15%.

Volume

The average weekly volume growth across all stocks in the Regional Banks Industry was 26%. For the same stocks of the Industry, the average monthly volume growth was 7% and the average quarterly volume growth was 30%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 51
Price Growth Rating: 49
SMR Rating: 37
Profit Risk Rating: 57
Seasonality Score: 36 (-100 ... +100)
Paper Trades 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a regional bank

Industry RegionalBanks

Industry
Regional Banks
Address
626 Washington Place
Phone
+1 800 555-5455
Employees
4282
Web
https://www.fnb-online.com
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
SAP's U.S. shares fell from Monday's close of $233.83 to $221.99 by late Tuesday morning in New York, a -5.06% decline recorded during regular trading hours. The company-specific trigger was the announced exit of Chief Customer Officer Thomas Saueressig, an executive board member since 2019, who will leave at the end of March 2027 to become CEO of IONOS; the disclosure came before the U.S. open.
Different growth engines: MRVL is riding accelerating AI data-center demand for custom chips and networking, while QCOM remains heavily tied to a soft smartphone market. Momentum contrast: Marvell's data-center revenue guidance has strengthened, whereas Qualcomm's near-term outlook has been pressured by memory-supply constraints and shrinking handset volumes.
TMC fell from Monday's $2.11 close to $1.96 by 10:10 a.m. ET, a -7.11% decline that occurred entirely in the regular session after an early premarket gain faded. No verified news or fundamental catalyst found for the drop; the move is likely technical, extending the post-Q3 unwind that followed NOAA pushing its certification decision to mid-December, with the stock averaging a 4.0% daily swing and logging 11 sessions of 7%-or-larger moves in the last 60.
IonQ slid from Monday's close of $26.45 to $24.73 on Tuesday, a -6.50% move that unfolded during regular trading hours after modest premarket gains faded. The decline was sector-driven rather than company-specific: quantum and AI-adjacent speculative names extended a multi-session liquidation ahead of Nvidia's quarterly report, with unease over Nvidia's abrupt CEO transition keeping risk appetite weak.